Newsroom

Press Release

NeoGenomics Signs Definitive Agreement to Acquire Clarient, Inc.

NeoGenomics Schedules its Q3 2015 Earnings Release for October 29, 2015

NeoGenomics Launches New NeoSITE™ Cervical FISH Assay for Evaluation of Abnormal Pap Tests

NeoGenomics Enters into National Agreement with Premier, Inc. to Offer Cancer Genetics Testing Services to 3,600 Hospitals

NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA

NeoGenomics Expands Multimodality Cancer Profile Testing

NeoGenomics Launches Germline Cancer Predisposition Testing

NeoGenomics Schedules its Q2 2015 Earnings Release for July 23, 2015

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients